3) haploidentical hematopoietic stem cell transplantation
单倍体相合造血干细胞移植
1.
The aim of this study was to evaluate the impact of donor killer cell immunoglobulin-like receptor(KIR)and recipient HLA genotypes on outcome following haploidentical hematopoietic stem cell transplantation(HSCT).
本研究探讨供者杀伤细胞免疫球蛋白样受体(KIR)和受者人类白细胞抗原(HLA)基因型在单倍体相合造血干细胞移植(HSCT)预后中的意义。
2.
To investigate the characteristics and significance of reconstitution of peripheral blood plasmacytoid dendritic cell (PDC) precursors after allogeneic human leukocyte antigen mismatched/ haploidentical hematopoietic stem cell transplantation, and its relationship with chronic graft versus host disease(cGVHD)and relapse, 19 patients with leukemia were enrolled for this study.
为了探讨浆样树突状细胞(PDC)在单倍体相合造血干细胞移植术后重建的特点及其与慢性移植物抗宿主病(cGVHD)和患者复发的关系,采用流式细胞术对19例白血病患者移植后外周血树突状细胞(DC)亚群晚期重建进行动态监测,并将其与患者cGVHD和复发的关系进行分析。
4) Mixed-HSCT
混合造血干细胞移植
1.
The clinical study of using DLI+IL-2 after Mixed-HSCT in acute myelogenous leukemia;
DLI+IL-2后续治疗混合造血干细胞移植后的急性髓性白血病
5) partially HLA-unmatched HSCT
HLA配型部分相合造血干细胞移植
6) hematopoietic stem cell transplantation
造血干细胞移植
1.
Clinical studies of unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignant diseases;
无血缘关系供者造血干细胞移植治疗恶性血液病的临床研究
2.
Correlation between blood concentrations of ciclosporin and its adverse drug reactions in immunosuppressive treatment of hematopoietic stem cell transplantation recipients;
造血干细胞移植中环孢素血药浓度与其不良反应的相关性研究
3.
Reviews of the Research on Hematopoietic Stem Cell Transplantation of Multiple Myeloma;
造血干细胞移植治疗多发性骨髓瘤的研究进展
补充资料：造血干细胞刺激因子
造血干细胞刺激因子
hemopoietic sti?mulating factor,CSF
诱导辅助细胞释放CSF，进而活化干细胞，可明显升高白细胞水平，用基因重组产生的CSF-1可活化巨噬细胞杀肿瘤活性，刺激单核细胞产生干扰素，肿瘤坏死因子可刺激造血细胞增生，促进细胞成熟和功能活化等，有临床应用价值。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条